Inogen, Inc. (INGN)
USD 6.84
(-2.98%)
USD 6.84
(-2.98%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 126.69 Million USD | -11.07% |
| 2022 | 153.53 Million USD | -13.0% |
| 2021 | 176.48 Million USD | 27.72% |
| 2020 | 138.18 Million USD | -19.6% |
| 2019 | 171.86 Million USD | -3.76% |
| 2018 | 178.58 Million USD | 47.3% |
| 2017 | 121.23 Million USD | 24.59% |
| 2016 | 97.31 Million USD | 27.61% |
| 2015 | 76.25 Million USD | 37.36% |
| 2014 | 55.51 Million USD | 42.38% |
| 2013 | 38.99 Million USD | 62.81% |
| 2012 | 23.94 Million USD | 62.87% |
| 2011 | 14.7 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 33.43 Million USD | 18.75% |
| 2024 Q2 | 47.15 Million USD | 41.0% |
| 2023 FY | 136.54 Million USD | -11.07% |
| 2023 Q4 | 28.15 Million USD | -16.6% |
| 2023 Q3 | 33.76 Million USD | -0.82% |
| 2023 Q2 | 34.04 Million USD | 10.77% |
| 2023 Q1 | 30.73 Million USD | 4.28% |
| 2022 Q1 | 35 Million USD | -9.28% |
| 2022 Q3 | 42.79 Million USD | -7.48% |
| 2022 Q2 | 46.25 Million USD | 32.14% |
| 2022 FY | 153.53 Million USD | -13.0% |
| 2022 Q4 | 29.47 Million USD | -31.14% |
| 2021 Q1 | 39.87 Million USD | 17.07% |
| 2021 Q2 | 50.33 Million USD | 26.24% |
| 2021 FY | 176.48 Million USD | 27.72% |
| 2021 Q3 | 47.68 Million USD | -5.26% |
| 2021 Q4 | 38.58 Million USD | -19.08% |
| 2020 Q4 | 34.05 Million USD | 3.19% |
| 2020 FY | 138.18 Million USD | -19.6% |
| 2020 Q3 | 33 Million USD | 0.78% |
| 2020 Q2 | 32.74 Million USD | -14.64% |
| 2020 Q1 | 38.36 Million USD | 13.1% |
| 2019 Q1 | 44.4 Million USD | 1.93% |
| 2019 FY | 171.86 Million USD | -3.76% |
| 2019 Q4 | 33.92 Million USD | -21.69% |
| 2019 Q3 | 43.31 Million USD | -13.74% |
| 2019 Q2 | 50.21 Million USD | 13.07% |
| 2018 Q4 | 43.57 Million USD | -10.74% |
| 2018 FY | 178.58 Million USD | 47.3% |
| 2018 Q3 | 48.81 Million USD | 0.71% |
| 2018 Q2 | 48.47 Million USD | 28.48% |
| 2018 Q1 | 37.72 Million USD | 22.67% |
| 2017 FY | 121.23 Million USD | 24.59% |
| 2017 Q1 | 25.74 Million USD | 4.28% |
| 2017 Q2 | 31.56 Million USD | 22.62% |
| 2017 Q3 | 33.17 Million USD | 5.08% |
| 2017 Q4 | 30.75 Million USD | -7.28% |
| 2016 FY | 97.31 Million USD | 27.61% |
| 2016 Q1 | 21.27 Million USD | 6.19% |
| 2016 Q3 | 25.12 Million USD | -4.15% |
| 2016 Q4 | 24.68 Million USD | -1.75% |
| 2016 Q2 | 26.21 Million USD | 23.2% |
| 2015 Q2 | 20.82 Million USD | 29.95% |
| 2015 Q4 | 20.03 Million USD | 3.42% |
| 2015 Q3 | 19.37 Million USD | -6.95% |
| 2015 Q1 | 16.02 Million USD | 15.97% |
| 2015 FY | 76.25 Million USD | 37.36% |
| 2014 Q4 | 13.81 Million USD | -5.69% |
| 2014 Q2 | 15.11 Million USD | 26.6% |
| 2014 Q1 | 11.93 Million USD | 17.33% |
| 2014 Q3 | 14.64 Million USD | -3.08% |
| 2014 FY | 55.51 Million USD | 42.38% |
| 2013 Q1 | 8.11 Million USD | 15.38% |
| 2013 Q2 | 11.05 Million USD | 36.22% |
| 2013 FY | 38.99 Million USD | 62.81% |
| 2013 Q4 | 10.17 Million USD | 5.53% |
| 2013 Q3 | 9.64 Million USD | -12.8% |
| 2012 Q4 | 7.03 Million USD | 8.3% |
| 2012 Q3 | 6.49 Million USD | 0.0% |
| 2012 FY | 23.94 Million USD | 62.87% |
| 2011 FY | 14.7 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -4868.588% |
| BrainsWay Ltd. | 23.09 Million USD | -448.694% |
| Cerus Corporation | 86.4 Million USD | -46.642% |
| Envoy Medical, Inc. | -473 Thousand USD | 26886.258% |
| electroCore, Inc. | 13.22 Million USD | -857.954% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -207603.279% |
| IceCure Medical Ltd | 1.3 Million USD | -9646.077% |
| OrthoPediatrics Corp. | 111.25 Million USD | -13.884% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 2194.198% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 267758.864% |
| MaxCyte, Inc. | 36.54 Million USD | -246.684% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -27653.402% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -148852.504% |
| Orthofix Medical Inc. | 486.27 Million USD | 73.945% |
| PAVmed Inc | -3.96 Million USD | 3293.019% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 2409.918% |
| RxSight, Inc. | 53.76 Million USD | -135.653% |
| Sight Sciences, Inc. | 69.17 Million USD | -83.157% |
| SI-BONE, Inc. | 109.42 Million USD | -15.791% |
| TELA Bio, Inc. | 40.11 Million USD | -215.863% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 16.611% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -1431.846% |
| Acutus Medical, Inc. | -3.13 Million USD | 4138.859% |
| Talis Biomedical Corporation | 371 Thousand USD | -34050.674% |
| Spectral AI, Inc. | 7.88 Million USD | -1507.855% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 2022.012% |
| CVRx, Inc. | 33.03 Million USD | -283.483% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -17032.461% |
| Bioventus Inc. | 328.19 Million USD | 61.395% |
| Venus Concept Inc. | 52.16 Million USD | -142.872% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -696.548% |
| LivaNova PLC | 771.25 Million USD | 83.572% |
| 908 Devices Inc. | 25.32 Million USD | -400.351% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 59.156% |
| Nemaura Medical Inc. | -1.47 Million USD | 8681.664% |
| NeuroPace, Inc. | 48.12 Million USD | -163.287% |
| LENSAR, Inc. | 21.1 Million USD | -500.27% |
| Apyx Medical Corporation | 14.12 Million USD | -797.175% |
| Cutera, Inc. | 41.49 Million USD | -205.343% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -586.306% |
| BioSig Technologies, Inc. | 18 Thousand USD | -703783.333% |
| Anika Therapeutics, Inc. | 103.08 Million USD | -22.904% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -830.652% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 85.738% |
| Axonics, Inc. | 274.55 Million USD | 53.853% |
| Outset Medical, Inc. | 29 Million USD | -336.893% |
| IRIDEX Corporation | 21.8 Million USD | -481.002% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | -78.326% |
| IRadimed Corporation | 50.15 Million USD | -152.598% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -44045.993% |
| INVO Bioscience, Inc. | 1.08 Million USD | -11565.092% |
| Telesis Bio, Inc. | 16.95 Million USD | -647.487% |
| Viemed Healthcare, Inc. | 112.78 Million USD | -12.339% |
| Varex Imaging Corporation | 256.9 Million USD | 50.682% |
| Quipt Home Medical Corp. | 163.84 Million USD | 22.671% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 31306.65% |
| Pulmonx Corporation | 50.75 Million USD | -149.643% |
| Dynatronics Corporation | 7.63 Million USD | -1559.455% |
| Modular Medical, Inc. | -768 Thousand USD | 16597.266% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -2183.688% |
| Semler Scientific, Inc. | 61.2 Million USD | -107.025% |
| InMode Ltd. | 411.34 Million USD | 69.198% |
| Bruker Corporation | 1.51 Billion USD | 91.647% |
| Cytosorbents Corporation | 22.39 Million USD | -465.822% |
| DexCom, Inc. | 2.28 Billion USD | 94.465% |
| Align Technology, Inc. | 2.71 Billion USD | 95.34% |
| Viveve Medical, Inc. | 620 Thousand USD | -20335.323% |
| ZimVie Inc. | 290.38 Million USD | 56.368% |
| Movano Inc. | -158 Thousand USD | 80289.241% |
| Cytek Biosciences, Inc. | 109.42 Million USD | -15.785% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -148852.504% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 65.542% |
| Profound Medical Corp. | 4.51 Million USD | -2706.788% |
| Insulet Corporation | 1.15 Billion USD | 89.077% |
| enVVeno Medical Corporation | -546 Thousand USD | 23304.945% |
| Surmodics, Inc. | 93.05 Million USD | -36.159% |
| iCAD, Inc. | 14.53 Million USD | -771.622% |
| Nuwellis, Inc. | 4.98 Million USD | -2442.625% |
| Biotricity, Inc. | 8.35 Million USD | -1416.213% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 61.815% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 35386.598% |
| InspireMD, Inc. | 1.8 Million USD | -6911.566% |
| PAVmed Inc. | -3.96 Million USD | 3293.019% |
| BIOLASE, Inc. | 16.72 Million USD | -657.588% |
| Beyond Air, Inc. | -1.3 Million USD | 9793.879% |
| FONAR Corporation | 45.14 Million USD | -180.68% |
| AxoGen, Inc. | 127.87 Million USD | 0.919% |
| Vivani Medical, Inc. | -357 Thousand USD | 35589.916% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 35.07% |
| Inari Medical, Inc. | 434.56 Million USD | 70.845% |
| UFP Technologies, Inc. | 112.22 Million USD | -12.897% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -1011953.678% |
| Tenon Medical, Inc. | 1.24 Million USD | -10109.428% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 156518.519% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -4722.791% |
| AdaptHealth Corp. | 479.56 Million USD | 73.58% |
| Sintx Technologies, Inc. | 1.84 Million USD | -6774.607% |
| NanoVibronix, Inc. | 1.53 Million USD | -8143.266% |
| Quanterix Corporation | 70.64 Million USD | -79.343% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 31306.65% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -801.131% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | -140.051% |
| TransMedics Group, Inc. | 154.09 Million USD | 17.778% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -2745.25% |
| NeuroMetrix, Inc. | 3.94 Million USD | -3109.672% |
| Hyperfine, Inc. | 4.75 Million USD | -2563.422% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | -18.436% |
| Biomerica, Inc. | 611 Thousand USD | -20636.334% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -203.926% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 16323.598% |
| Silk Road Medical, Inc | 127.08 Million USD | 0.305% |